Cointime

Limula

company

About

Limula provides a unique platform technology that enables scale out of cell therapy manufacturing, directly at the point of care.

  • 1 - 10

Highlights

Total Funding Amount
€4.70M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€4.70M
Industries
Biotechnology,Genetics,Manufacturing,Pharmaceutical
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Limula provides a unique platform technology enabling scale out of cell therapy production. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments. Our patented solution is composed of an automation unit and single use kits, allowing healthcare providers to safely manufacture CGT in a decentralized manner. We support companies at all stages of the cell therapy life cycle, from R&D to routine production.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€4.70M
Limula has raised a total of €4.70M in funding over 2 rounds. Their latest funding was raised on Jun 15, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 15, 2022 Grant €4.70M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Limula is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท